Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 μg/m2) after salvage chemotherapy for lymphoma

Bone Marrow Transplantation

Volumn 20, Issue 10, 1997, Pages 855-858

  Martinez C ^a   Sureda, A ^a   Martino, R ^a   Cancelas, J A ^b   Madoz, P ^a   Garcia J ^b   Brunet, S ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Institut de Recerca Oncologica   (Spain)

Author keywords

Chemotherapy; G CSF; Lymphoma; PBSC mobilization

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LYMPHOMA; MALE; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

EID: 1842417178     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700990     Document Type: Article

References (18)

1. To LB, Shepperd KM, Haylock DN et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442-447.
2. Rosenfeld CS, Bolwell B, LeFever A et al. Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone Marrow Transplant 1996; 17: 179-183.
3. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus G-CSF. Exp Hematol 1993; 21: 508-514.
4. Tarella C, Caracciolo D, Gavarotti P et al. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 1995; 16: 223-228
5. Dreger P, Marquardt P, Haferlach T et al. Effective mobilisation of peripheral blood progenitor cells with Dexa-Beam and G-CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993; 68: 950-957.
6. Garcia J, Martinez E. La criopreservación de precursores hematopoyéticos: su papel en Hematologîa y Oncología. Bio Clin Hematol 1983; 5: 99-107.
7. Pike BL, Robinson WA. Human bone marrow colony growth in agar gel. J Cell Physiol 1970; 76: 77-84.
8. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftmenl of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
9. Sheridan WP, Begley CG, To LB et al. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994;14: 105-111.
10. Martínez C, Mateu R, Sureda A et al. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma. Transplant Proc 1995; 27: 2355-2356.
11. Zeller W, Gutensohn K, Stockschläder M et al. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant 1996; 17: 709-713.
12. Shimazaki C, Oku N, Ashihara E et al. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant 1992; 10: 341-346.
13. Kohno A, Takeyama K, Narabayashi M el al. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor. Bone Marrow Transplant 1995; 15: 49-54.
14. Haynes A, Hunter A, McQuaker G et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995; 16: 359-363.
15. Haas R, Moos M, Möhler R el al. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 17: 149-155.
16. Akard LP, Wiemann M, Thompson JM et al. Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide and G-CSF. J Hematother 1996; 5: 271-277.
17. Haas R, Möhle R, Fruhauf S et al. Patient characteristics of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
18. Martínez E, Sureda A, De Dalmases C et al. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma. Bone Marrow Transplant 1996: 18: 1-7.